X

pharmaceuticals

Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and…

Eli Lilly and Company Q2 2023 Earnings Conference Call Insights

Key highlights from Eli Lilly and Company (LLY) Q2 2023 Earnings Concall Q&A Highlights: [00:36:01] Louise Chen from Kantor asked…

Earnings Summary: Bio-Techne Corp (TECH) reports higher Q4 profit, revenue

Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Tuesday announced financial results for the fourth quarter of 2023, reporting an increase…

LLY Earnings: Key quarterly highlights from Eli Lilly’s Q2 2023 financial results

Eli Lilly and Company (NYSE: LLY) reported second quarter 2023 earnings results today. Revenue increased 28% to $8.3 billion compared…

AMGN Earnings: Everything you need to know about Amgen’s Q2 results

Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology…

Gilead Sciences (GILD) Earnings: 2Q23 Key Numbers

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.6 billion for the second quarter of 2023, which was up…

Cigna Corporation Q2 2023 Earnings Conference Call Insights

Key highlights from Cigna Corporation (CI) Q2 2023 Earnings Concall Q&A Highlights: [00:21:37] Scott Fidel with Stephens asked how are…

REGN Earnings: Regeneron Pharma reports higher Q2 profit and revenue

Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the second…

Moderna, Inc Q2 2023 Earnings Conference Call Insights

Key highlights from Moderna, Inc (MRNA) Q2 2023 Earnings Concall Management Update: [00:16:30] MRNA’s COVID sales expectations for 2023 are…

CI Earnings: A snapshot of Cigna’s Q2 2023 financial results

Healthcare company The Cigna Group (NYSE: CI) on Thursday reported a 7% increase in revenues for the second quarter of…

Infographic: Moderna (MRNA) Q2 2023 Earnings Results

Moderna, Inc. (NASDAQ: MRNA) reported second quarter 2023 earnings results today. Total revenue dropped to $344 million from $4.7 billion…

Earnings Summary: A snapshot of McKesson Corporation’s Q1 2024 report

McKesson Corporation (NYSE: MCK), a diversified healthcare service company that operates in partnership with biopharma companies, care providers, pharmacies, and…

CVS Health Corporation Q2 2023 Earnings Conference Call Insights

Key highlights from CVS Health Corporation (CVS) Q2 2023 Earnings Concall Management Update: [00:14:22] CVS said its restructuring efforts are…

Vertex Pharmaceuticals (VRTX) Earnings: 2Q23 Key Numbers

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14%…

CVS Health Q2 2023 earnings drop despite higher revenues

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced second-quarter 2023 results, reporting lower earnings despite an increase in revenues. June…

AmerisourceBergen Corporation (ABC) Q3 2023 Earnings Summary

AmerisourceBergen Corporation (NYSE: ABC) reported third quarter 2023 earnings results today. Revenue increased 11.5% year-over-year to $66.9 billion. Net income…

Key takeaways from Pfizer’s (PFE) Q2 2023 earnings report

Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday after the company delivered mixed results for the…

Merck & Co., Inc. Q2 2003 Earnings Conference Call Insights

Key highlights from Merck & Co., Inc. (MRK) Q2 2023 Earnings Concall Management Update: [00:18:54] MRK said it will continue…

Infographic: Key highlights from Merck’s (MRK) Q2 2023 earnings results

Merck (NYSE: MRK) reported second quarter 2023 earnings results today. Total worldwide sales were $15 billion, up 3% from the…

PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results

Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today. Revenues decreased 54% year-over-year to $12.7 billion. Reported net…

Earnings Summary: All you need to know about DexCom’s Q2 report

Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance. Second-quarter revenue…